CDC panel to discuss Johnson & Johnson, Moderna COVID-19 boosters
A Centers for Disease Control panel will meet to discuss COVID-19 booster shots for Johnson & Johnson and Moderna.
A Centers for Disease Control panel will meet to discuss COVID-19 booster shots for Johnson & Johnson and Moderna.
More booster shots could be on the way. An FDA advisory committee voted on Moderna’s booster dose Thursday.
Consumer News: Officials warn of new online scam, advisors discuss more COVID-19 boosters and more
U.S. health advisers said Thursday that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus.
Vaccine advisors are set to discuss mixing and matching COVID-19 vaccines Friday.
With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson & Johnson vaccine wait anxiously to learn when it’s their turn.
White House officials have also announced a plan to offer a booster shots to fully vaccinated Americans who got the Pfizer or Moderna vaccine. They are citing new evidence of waning vaccine protection over time, but where does that leave the Johnson & Johnson vaccine when it comes to boosters?
Moderna said Monday it plans to expand the size of its COVID-19 vaccine study in younger children to better detect rare side effects, such as a type of heart inflammation recently flagged by U.S. health authorities.
A promising new study has been released for those getting vaccinated against COVID-19. The Pfizer and Moderna vaccines could provide protection from the coronavirus for years and potentially reduce the use of requiring booster shots.
Folks could get a free beer at River Rat Brewery today by getting vaccinated through DHEC’s “Shot and a Chaser” campaign.